Human papillomavirus as an independent risk factor of invasive cervical and endometrial carcinomas in Jordan

被引:19
作者
Abu-Lubad, Mohammad A. [1 ]
Jarajreh, Dua'a A. [1 ]
Helaly, Ghada F. [1 ,2 ]
Alzoubi, Hamed M. [1 ]
Haddadin, Weliam J. [3 ]
Dabobash, Mahmoud D. [4 ]
Albataineh, Eman M. [1 ]
Aqel, Amin A. [1 ]
Alnawaiseh, Nedal A. [5 ]
机构
[1] Mutah Univ, Fac Med, Med Microbiol & Immunol Dept, Al Karak, Jordan
[2] Alexandria Univ, Med Res Inst, Microbiol Dept, Alexandria, Egypt
[3] Royal Med Serv, Pathol Dept, Amman, Jordan
[4] Al Bashir Hosp, Pathol Dept, Amman, Jordan
[5] Mutah Univ, Fac Med, Community Med & Publ Hlth Dept, Al Karak, Jordan
关键词
Human papillomavirus; Invasive cervical carcinoma; Endometrial carcinoma; Chlamydia trachomatis; CHLAMYDIA-TRACHOMATIS; INTRAEPITHELIAL NEOPLASIA; IN-SITU; CANCER; WOMEN; PREVALENCE; HPV; INFECTION; GENOTYPES; LESIONS;
D O I
10.1016/j.jiph.2019.08.017
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Endometrial and cervical carcinomas are the most common gynecologic malignancies in Western world and many countries. The human papillomavirus (HPV) high-risk genotypes are associated with cervical carcinoma (CC). Chlamydia trachomatis (C. trachomatis), the most common sexually transmitted bacterial infection worldwide, considered a cofactor for HPV infection and CC. Information on HPV infection rate and type distribution among Jordanian women having CC is currently limited and unavailable among those with endometrial carcinoma. Therefore, the present study aimed to provide an updated estimate on HPV infection rate and its high-risk genotypes' distribution among Jordanian women by comparing data from invasive cervical carcinoma (ICC) to normal cervical tissues. Similarly, assessment of HPV infection rate was extended to the endometrial tissues. C. trachomatis infection was investigated as well to explore its possibility as HPV cofactor for induction of such carcinomas. Methods: Total DNA was extracted from 144 formaldehyde-fixed paraffin-embedded cervical and endometrial tissue, equally divided between age-matched control and carcinoma cases. Polymera se chain reaction (PCR) was used for general detection of HPV-DNA, high risk HPV-16 and 18 genotypes and C. trachomatis DNA using specific primers. Results: HPV infection was detected in 91.7% and 61.1% of cervical cancer patients and controls, respectively. Likewise, it was higher among cases (47.2%) than controls (13.8%) in endometrial biopsies. Significantly higher HPV infection rates were found among ICC and endometrial control biopsies of women >50 years. Out of 33 HPV positive ICC cases, single HPV-16 infections were detected in 69.7% compared to HPV-18 (15.2%), while HPV-16/18 co-infections were only found in three (9%) samples. C. trachomatis was not detected in all studied groups. Conclusion: The present study has successfully provided an updated estimate on HPV infection rate among Jordanian women with and without ICC and endometrial carcinoma. In addition, a lack of co -infection was observed between HPV and C. trachomatis in both cancer types. (C) 2019 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences.
引用
收藏
页码:613 / 618
页数:6
相关论文
共 48 条
  • [1] Chlamydia trachomatis Inhibits Inducible NO Synthase in Human Mesenchymal Stem Cells by Stimulating Polyamine Synthesis
    Abu-Lubad, Mohammad
    Meyer, Thomas F.
    Al-Zeer, Munir A.
    [J]. JOURNAL OF IMMUNOLOGY, 2014, 193 (06) : 2941 - 2951
  • [2] Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia
    AlObaid, Abdulaziz
    Al-Badawi, Ismail A.
    Al-Kadri, Hanan
    Gopala, Kusuma
    Kandeil, Walid
    Quint, Wim
    Al-Aker, Murad
    DeAntonio, Rodrigo
    [J]. BMC INFECTIOUS DISEASES, 2014, 14
  • [3] HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia
    Alsbeih, Ghazi
    Al-Harbi, Najla
    El-Sebaie, Medhat
    Al-Badawi, Ismail
    [J]. INFECTIOUS AGENTS AND CANCER, 2013, 8
  • [4] Reduced Rate of Human Papillomavirus Infection and Genetic Overtransmission of TP53 72C Polymorphic Variant Lower Cervical Cancer Incidence
    Alsbeih, Ghazi A.
    Al-Harbi, Najla M.
    Bin Judia, Sara S.
    Khoja, Hatim A.
    Shoukri, Mohamed M.
    Tulbah, Asma M.
    [J]. CANCER, 2017, 123 (13) : 2459 - 2466
  • [5] [Anonymous], 2008, SPSS S 160 WIND
  • [6] Awwad Ziad M., 2003, International Journal of Infectious Diseases, V7, P206, DOI 10.1016/S1201-9712(03)90053-1
  • [7] Detection of Human Papillomavirus 16, 18, and 45 in Women With ASC-US Cytology and the Risk of Cervical Precancer Results From the CLEAR HPV Study
    Castle, Phillip E.
    Cuzick, Jack
    Stoler, Mark H.
    Wright, Thomas C., Jr.
    Reid, Jennifer L.
    Dockter, Janel
    Giachetti, Cristina
    Getman, Damon
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (02) : 160 - 167
  • [8] Worldwide distribution of human papillomavirus types in cytologically normal women in the international Agency for Research on Cancer HPV prevalence surveys:: a pooled analysis
    Clifford, GM
    Gallus, S
    Herrero, R
    Muñoz, N
    Snijders, PJF
    Vaccarella, S
    Anh, PTH
    Ferreccio, C
    Hieu, NT
    Matos, E
    Molano, M
    Rajkumar, R
    Ronco, G
    de Sanjosé, S
    Shin, HR
    Sukvirach, S
    Thomas, JO
    Tunsakul, S
    Meijer, CJLM
    Franceschi, S
    [J]. LANCET, 2005, 366 (9490) : 991 - 998
  • [9] Prospective Seroepidemiologic Study of Human Papillomavirus and Other Risk Factors in Cervical Cancer
    Dahlstrom, Lisen Arnheim
    Andersson, Kristin
    Luostarinen, Tapio
    Thoresen, Steinar
    Ogmundsdottir, Helga
    Tryggvadottir, Laufey
    Wiklund, Fredrik
    Skare, Gry B.
    Eklund, Carina
    Sjolin, Kia
    Jellum, Egil
    Koskela, Pentti
    Wadell, Goran
    Lehtinen, Matti
    Dillner, Joakim
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (12) : 2541 - 2550
  • [10] A population-based study of squamous cell vaginal cancer: HPV and cofactors
    Daling, JR
    Madeleine, MM
    Schwartz, SM
    Shera, KA
    Carter, JJ
    McKnight, B
    Porter, PL
    Galloway, DA
    McDougall, JK
    Tamimi, H
    [J]. GYNECOLOGIC ONCOLOGY, 2002, 84 (02) : 263 - 270